Thomas John Charles
SEC CIK 2114900 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | EVP, GC | 1,000 | — | $541.2K | 3 | 2026-05-26 | 2026-06-25 |
Most active insiders at KRYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krishnan Suma | Pres, R, D, Dir, 10% | — | $34.27M |
| 2 | Krishnan Krish S | Pres, CEO, Dir, 10% | — | $34.27M |
| 3 | JANNEY DANIEL | Dir | — | $19.40M |
| 4 | ROSSI DINO A | Dir | — | $13.18M |
| 5 | ROMANO KATHRYN | CAO | — | $3.60M |
| 6 | Thomas John Charles | EVP, GC | — | $541.2K |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-26 18:45 | 2026-06-25 | KRYS | Krystal Biotech, Inc. | Thomas John Charles | EVP, GC | M - OptEx | $179.25 | +1,000 | 1,000 | New | +$179.2K |
| DT | 2026-06-26 18:45 | 2026-06-25 | KRYS | Krystal Biotech, Inc. | Thomas John Charles | EVP, GC | S - Sale+OE | $347.27 | -1,000 | 0 | -100% | -$347.3K |
| T | 2026-05-27 17:17 | 2026-05-26 | KRYS | Krystal Biotech, Inc. | Thomas John Charles | EVP, GC | S - Sale | $302.03 | -642 | 0 | -100% | -$193.9K |
Purchase Sale Sale after option exercise All abbreviations